AMH and Infertility: Although more women had ovulation disorders in the relugolix group than in the injection group, there were no significant differences in patients' age, pregnancy history, other causes of infertility, previous history of ET cycles, AMH levels, ovarian stimulation with and without clomiphene citrate, oocyte maturation procedure, or hormone data at the day of trigger administration.